Q1 2027 Clean Science and Technology Ltd Earnings Call Transcript
Key Points
- Clean Science and Technology Ltd (BOM:543318) reported its highest-ever consolidated sales of approximately INR264 crores, with a 7% sequential growth and a 10% YoY increase, driven by the consistent scale-up of its HALS business.
- The HALS business achieved a significant milestone by becoming operationally self-sustaining, with exports contributing nearly 50% of HALS sales, and the company has derisked its reliance on top four legacy products by reducing their share from 85% in Q4 FY23 to 60%.
- The company entered into a strategic collaboration with Swiss partner Geneus Chem to manufacture advanced NOR HALS, which is expected to generate INR300-350 crores of additional revenue over the next 3-4 years and provide entry into a new, higher-margin market.
- Clean Science and Technology Ltd (BOM:543318) secured a five-year supply agreement with Kemin, the world's largest buyer of certain ingredients, which is expected to increase offtake by 20-40% and provide assured volumes.
- The hydroquinone and catechol plant has been largely stabilized, with customer approvals received and commercial supplies ramping up, which is expected to gradually increase revenue in the coming quarters.
- The company's EBITDA and PAT margins remained strong at 43% and 36% respectively on a standalone basis, with management indicating that these margin levels are sustainable due to improved product mix and operational efficiencies.
- The company faced significant geopolitical headwinds, including raw material supply chain disruptions and non-availability of shipping vessels, which impacted timely exports and led to a 6% YoY decline in standalone sales.
- Raw material costs in China were not impacted as much as in India, creating a competitive disadvantage, and the company was unable to pass on 100% of input cost increases to customers due to long-term contracts.
- The Performance Chemical 2 plant has been delayed due to labor issues and is now expected to commercialize in November, with major revenue contribution only expected from Q1 FY28.
- The company experienced a two-week production shutdown in Q1 due to a key Indian supplier's facility closure, which negatively impacted volumes and revenue.
- Raw material price volatility remains a persistent issue, and management noted that while supply availability has improved, profitability could still be affected by fluctuating crude oil prices and geopolitical tensions.
- The company had to infuse approximately INR100 crores into its subsidiary during the quarter, bringing total investment to INR850 crores, indicating significant capital requirements for the HALS business.
Ladies and gentlemen, good day, and welcome to the Q1 FY27 earnings conference call of Clean Science and Technology Limited. We have with us on the call Siddharth Sikchi, Managing Director and Promoter; Sanjay Parnerkar, CFO; and Pratik Bora, President, Commercial. (Operator Instructions)
I now hand the conference over to Mr. Siddharth Sikhi for opening remarks. Thank you, and over to you, Mr. Siddharth Sikchi.
Thank you so much, Ikra. Good evening, everybody. Thank you so much for attending the call on a Saturday evening. So let me start by welcoming everyone and a warm welcome for the quarter one FY27 earnings call of the company, and I thank you for joining the call. Let me first speak on the business environment.
The quarter performance shall be viewed in backdrop of geopolitical headwinds impacting raw material supply chain and its cost. Nonavailability of shipping vessels impacted timely export of goods, leading to supply side challenges. Further, the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
